<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Jaegere, A.P.M.C. de</title>
    <link>http://repub.eur.nl/res/aut/13711/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Reducing atelectasis attenuates bacterial growth and translocation in experimental pneumonia. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13310/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>Besides being one of the mechanisms responsible for ventilator-induced
      lung injury, atelectasis also seems to aggravate the course of
      experimental pneumonia. In this study, we examined the effect of reducing
      the degree of atelectasis by natural modified surfactant and/or open lung
      ventilation on bacterial growth and translocation in a piglet model of
      Group B streptococcal pneumonia. After creating surfactant deficiency by
      whole lung lavage, intratracheal instillation of bacteria induced severe
      pneumonia with bacterial translocation into the blood stream, resulting in
      a mortality rate of almost 80%. Treatment with 300 mg/kg of exogenous
      surfactant before instillation of streptococci attenuated both bacterial
      growth and translocation and prevented clinical deterioration. This goal
      was also achieved by reversing atelectasis in lavaged animals via open
      lung ventilation. Combining both exogenous surfactant and open lung
      ventilation prevented bacterial translocation completely, comparable to
      Group B streptococci instillation into healthy animals. We conclude that
      exogenous surfactant and open lung ventilation attenuate bacterial growth
      and translocation in experimental pneumonia and that this attenuation is
      at least in part mediated by a reduction in atelectasis. These findings
      suggest that minimizing alveolar collapse by exogenous surfactant and open
      lung ventilation may reduce the risk of pneumonia and subsequent sepsis in
      ventilated patients.</description>
    </item> <item>
      <title>High-frequency oscillatory ventilation is not superior to conventional mechanical ventilation in surfactant-treated rabbits with lung injury (Article)</title>
      <link>http://repub.eur.nl/res/pub/9198/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>The aim of this study was to compare high-frequency oscillatory
          ventilation (HFOV) with conventional mechanical ventilation (CMV) with and
          without surfactant in the treatment of surfactant-deficient rabbits. A
          previously described saline lung lavage model of lung injury in adult
          rabbits was used. The efficacy of each therapy was assessed by evaluating
          gas exchange, lung deflation stability and lung histopathology. Arterial
          oxygenation did not improve in the CMV group without surfactant but
          increased rapidly to prelavage values in the other three study groups.
          During deflation stability, arterial oxygenation decreased to postlavage
          values in the group that received HFOV alone, but not in both
          surfactant-treated groups (HFOV and CMV). The HFOV group without
          surfactant showed more cellular infiltration and epithelial damage
          compared with both surfactant-treated groups. There was no difference in
          gas exchange, lung deflation stability and lung injury between HFOV and
          CMV after surfactant therapy. It is concluded that the use of surfactant
          therapy in combination with high-frequency oscillatory ventilation is not
          superior to conventional mechanical ventilation in improving gas exchange,
          lung deflation stability and in the prevention of lung injury, if lungs
          are kept expanded. This indicates that achieving and maintaining alveolar
          expansion (i.e. open lung) is of more importance than the type of
          ventilator.</description>
    </item> <item>
      <title>Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension (Article)</title>
      <link>http://repub.eur.nl/res/pub/8932/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Does endotracheal instilled prostacyclin (epoprostenol) improve
          oxygenation in preterm infants with persistent pulmonary hypertension?
          Four preterm infants were studied. Prostacyclin (50 ng x kg(-1)) was
          injected as an endotracheal bolus. In two patients the prostacyclin bolus
          was repeated and in one patient prostacyclin was administered
          continuously. Oxygenation was evaluated through the oxygenation index and
          the ratio of arterial oxygen tension to the fraction of inspired oxygen.
          The mean arterial blood pressure was used to evaluate systemic
          circulation. The oxygenation index (+/-SD) decreased significantly from 39
          (+/-13.3) to 7 (+/-2.5) and the ratio of arterial oxygen tension to the
          fraction of inspired oxygen (+/-SD) increased significantly from 47
          (+/-13) to 218 (+/-67), most likely related to a reduction of the
          pulmonary vascular resistance with a reversal of the extrapulmonary
          shunting at the ductus arteriosus and atrial level. The blood pressure did
          not change. All effects were reversed on drug withdrawal. Repeated or
          continuous endotracheal administration of prostacyclin in three children
          demonstrated a sustained response without tachyphylaxis, and without overt
          side-effects. Endotracheal instillation of prostacyclin resulted in an
          improved oxygenation without systemic vascular repercussions in four
          preterm infants with persistent pulmonary hypertension. Repeated or
          continuous administration showed a sustained response and no overt
          side-effects were noticed.</description>
    </item>
  </channel>
</rss>